Rehmann Capital Advisory Group Purchases Shares of 633 Waters Corporation $WAT

Rehmann Capital Advisory Group acquired a new stake in shares of Waters Corporation (NYSE:WAT) in the second quarter, Holdings Channel.com reports. The firm acquired 633 shares of the medical instruments supplier’s stock, valued at approximately $221,000.

A number of other institutional investors have also added to or reduced their stakes in WAT. Olde Wealth Management LLC bought a new position in Waters during the first quarter valued at about $25,000. Zions Bancorporation National Association UT bought a new position in Waters during the first quarter valued at about $28,000. IFP Advisors Inc increased its stake in Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after acquiring an additional 44 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in Waters during the first quarter valued at about $41,000. Finally, Steph & Co. bought a new position in Waters during the second quarter valued at about $73,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on WAT. Wall Street Zen lowered Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Redburn Partners set a $390.00 price target on Waters in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the company a “hold” rating in a research note on Tuesday, August 5th. Robert W. Baird lowered their price target on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research report on Friday. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, Waters currently has an average rating of “Moderate Buy” and an average target price of $376.80.

Waters Stock Performance

NYSE:WAT opened at $358.79 on Friday. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $21.36 billion, a PE ratio of 32.35, a price-to-earnings-growth ratio of 3.30 and a beta of 1.04. The firm has a 50-day moving average price of $311.56 and a 200 day moving average price of $323.80.

Waters (NYSE:WAT) last posted its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. The firm had revenue of $608.55 million during the quarter. Research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.